Should we be itching for a CCL2 itch and pain medicine?

Patrick M. Dougherty

doi:10.1016/j.bbi.2019.06.044

Should we be itching for a CCL2 itch and pain medicine?

Patrick M. Dougherty

Pain Medicine

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	12-13
Number of pages	2
Journal	Brain, behavior, and immunity
Volume	81
DOIs	https://doi.org/10.1016/j.bbi.2019.06.044
State	Published - Oct 2019

ASJC Scopus subject areas

Immunology
Endocrine and Autonomic Systems
Behavioral Neuroscience

Access to Document

10.1016/j.bbi.2019.06.044

Cite this

@article{ba15d07475364afe84a362e2140a6ea7,

title = "Should we be itching for a CCL2 itch and pain medicine?",

author = "Dougherty, {Patrick M.}",

note = "Funding Information: This work was supported by NIH grant CA200263, The Thompson Family Foundation Initiative and the H.E.B. Endowment in Cancer Research. Funding Information: This work was supported by NIH grant CA200263, The Thompson Family Foundation Initiative and the H.E.B. Endowment in Cancer Research.",

year = "2019",

month = oct,

doi = "10.1016/j.bbi.2019.06.044",

language = "English (US)",

volume = "81",

pages = "12--13",

journal = "Brain, behavior, and immunity",